Additionally, as an essential for NF-κB stimulation, RBCK1 mutations are shown to be related to immunodeficiency and tumor-infiltrating immune cells, which proved to be an independent prognostic biomarker in RCC (71, 72). This evidence concerns the gene RBCK1 and renal cell carcinoma.